Sort
39,280 grants matching “leukemia”
Reconstitution of Regulatory T Cells after Allogeneic Stem Cell Transplantation
$379,643Jerome Ritz · Dana-Farber Cancer Inst · U19 · FY2009 · AI
Assessment of Clinical Retinoid Activity in Leukemia
$379,637Robert E Gallagher · Montefiore Medical Center (Bronx, Ny) · R01 · FY2007 · CA
UNIVERSITY OF COLORADO SOUTHWEST ONCOLOGY GROUP
$379,635University Of Colorado Denver · U10 · FY2001 · CA
Epigenetic Control of Hematopoietic Gene Expression
$379,625Gerd A Blobel · Children'S Hosp Of Philadelphia · R37 · FY2015 · DK
Epigenetic Control of Hematopoietic Gene Expression
$379,625Gerd A Blobel · Children'S Hosp Of Philadelphia · R37 · FY2016 · DK
Epigenetic Control of Hematopoietic Gene Expression
$379,625Gerd A Blobel · Children'S Hosp Of Philadelphia · R37 · FY2019 · DK
Epigenetic Control of Hematopoietic Gene Expression
$379,625Gerd A Blobel · Children'S Hosp Of Philadelphia · R37 · FY2017 · DK
Immunogenetics of Graft-Versus-Host Disease
$379,587Effie W Petersdorf · Fred Hutchinson Cancer Research Center · P01 · FY2011 · CA
Pre-clinical Studies of Therapy for Myelodysplastic Syndrome
$379,578Peter Aplan · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Activation of Proto-Oncogenes by Chromosomal Translocation
$379,578Peter Aplan · Division Of Clinical Sciences - Nci · ZIA · FY2009 · CA
Collaborative Pathways that Lead to Leukemia
$379,578Peter Aplan · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Mechanisms of differentiation blockade in CSF3R-mutant AML
$379,538Julia E Maxson · Oregon Health & Science University · R01 · FY2021 · CA
Mechanisms of differentiation blockade in CSF3R-mutant AML
$379,538Julia E Maxson · Oregon Health & Science University · R01 · FY2025 · CA
Mechanisms of differentiation blockade in CSF3R-mutant AML
$379,538Julia E Maxson · Oregon Health & Science University · R01 · FY2022 · CA
Targeting novel DAMP mediated signaling pathways to mitigate GVHD
$379,528Pavan Reddy · University Of Michigan At Ann Arbor · R01 · FY2021 · CA
Collaborative Pathways that Lead to Leukemia
$379,492Peter Aplan · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Activation of Proto-Oncogenes by Chromosomal Translocation
$379,492Peter Aplan · Division Of Clinical Sciences - Nci · ZIA · FY2010 · CA
Mechanisms of Chromosomal Translocation
$379,492Peter Aplan · Division Of Clinical Sciences - Nci · ZIA · FY2010 · CA
Pre-clinical Studies of Therapy for Myelodysplastic Syndrome
$379,492Peter Aplan · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Multiplexed Nanoparticle Probes for Therapeutic Translational Oncology
$379,473Jonathan W Simons · Emory University · U54 · FY2009 · CA
Histologic and Molecular Characterization of Solid Pediatric Tumors
$379,468Maria Tsokos · Division Of Clinical Sciences - Nci · ZIC · FY2009 · CA
Fanconi Anemia stem cells allow molecular characterization of acute leukemia
$379,440David W. Clapp · Indiana University Indianapolis · R01 · FY2012 · CA
Oncogenic pathways and therapeutic targets in T cell acute lymphoblastic leukemia
$379,427David Michael Langenau · Massachusetts General Hospital · R01 · FY2019 · CA
Leveraging the TCR Repertoire to identify target neoantigens in FLT3-ITD positive Acute Myeloid Leukemia
$379,419Houda Alachkar · University Of Southern California · R01 · FY2021 · CA
Favored Sites for HIV Integration in the Human Genome
$379,400Salk Institute For Biological Studies · R01 · FY2002 · AI